Delivery Order SPE2DB22D2214-SPE2DB26FS2KA
- Not listed
- The Defense Logistics Agency awarded a $3,604.57 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg. This competitive delivery order, which is set to be completed by September 18, 2025, represents a firm fixed-price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $5,258.71. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,794.12 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Pantoprazole Sodium delayed-release 40 milligram on September 4, 2025, with completion scheduled for September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium Delayed-Release 20 mg tablets (90-count) with a ceiling value of $10,425.69. This competitively awarded, non-set-aside contract with firm fixed pricing is effective through September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $24,742.17 firm-fixed price contract has a performance period through February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,058.66. This competitive award, which utilizes firm fixed price pricing, represents a non-set-aside contract and is scheduled for completion by August 29, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,119.58 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on September 17, 2025, with performance occurring at the vendor's corporate office location in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.04 firm fixed-price delivery order is for the supply of 4,567,752,489 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, with a period of performance through April 1, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,576.34 firm-fixed-price delivery order is for the supply of 4,558,762,323 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of October 14, 2022 and does not include any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,429.01 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract, issued under firm fixed-price terms with no set-aside designation, calls for the delivery of Pantoprazole DR 40 mg suspension packets in quantities of 30. This delivery order represents a child...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB26FS2KADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,133.16 to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium delayed-release 40 mg tablets (1,000 count) with a completion date of October 16, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The award represents a single transaction within AmerisourceBergen's broader relationship with the Defense Logistics Agency, where the company serves as a critical vendor for military and federal healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, maintains a significant portfolio of federal contracts characterized by competitive awards and firm fixed pricing across multiple therapeutic domains, positioning the company as a key pharmaceutical distributor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/15/25 |